AMGN Named A Top Socially Responsible Dividend Stock

Amgen (AMGN) is noted for its inclusion in key ESG-focused exchange-traded funds, comprising 0.34% of the iShares MSCI USA ESG Select ETF (SUSA) and 0.54% of the iShares MSCI KLD 400 Social Index Fund ETF (DSI). The biotechnology company currently pays an annualized dividend of $9.52/share, distributed quarterly, with its most recent ex-dividend date set for February 14, 2025. This dividend profile, particularly its historical consistency, is highlighted as a critical factor for assessing future payout sustainability for investors.

Analysis

Amgen Inc. (AMGN) is positioned as a noteworthy component for socially responsible investment strategies, evidenced by its inclusion in key ESG funds; it constitutes 0.34% of the iShares MSCI USA ESG Select ETF (SUSA) and 0.54% of the iShares MSCI KLD 400 Social Index Fund ETF (DSI). From a capital return perspective, the company maintains an annualized dividend of $9.52 per share, paid quarterly, with a recent ex-dividend date of February 14, 2025. The central analytical point emphasized is the importance of examining the company's long-term dividend history to assess the sustainability of its current payout. This focus on dividend track record serves as a critical due diligence step for income-oriented investors evaluating AMGN within the context of the broader Biotechnology sector, which includes peers like Thermo Fisher Scientific (TMO) and Danaher Corp (DHR).

Key Decisions for Investors

• Investors with an ESG mandate should recognize Amgen's weighting in the SUSA and DSI ETFs as a positive qualifier for socially responsible portfolios.
• Income-focused investors are advised to analyze Amgen's historical dividend record to gauge the sustainability of the current $9.52 per share annual dividend.